There is some concern among investors that GLP-1 receptor agonists — Ozempic, Wegovy, semalglutide, etc. — will be so popular and so successful at curtailing appetites that it will affect the value of companies that make and sell alcohol and junk food. Walmart’s CEO, for example, claimed
Reminds me a bit of the ‘tune in, drop out’ era that came with LSD before it got wiped out the way and illegalised. But perhaps there’s a shift coming because the media seems to be suddenly fixated on the ‘new’ discoveries about ultra processed foods and encouraging health vs cures and this has never been championed in mainstream
Talk to me when they make a pill that reduces self obsession. THAT will have the suits scared. Great as always Rob!
🤯🤯 loved this rob
Every paragraph here deserves its own JG Ballard novel. So good.
Feels hopeful. And really well observed.
Reminds me a bit of the ‘tune in, drop out’ era that came with LSD before it got wiped out the way and illegalised. But perhaps there’s a shift coming because the media seems to be suddenly fixated on the ‘new’ discoveries about ultra processed foods and encouraging health vs cures and this has never been championed in mainstream